Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2397601
Max Phase: Preclinical
Molecular Formula: C13H10N4
Molecular Weight: 222.25
Molecule Type: Small molecule
Associated Items:
ID: ALA2397601
Max Phase: Preclinical
Molecular Formula: C13H10N4
Molecular Weight: 222.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1cc2cn[nH]c2c2c1[nH]c1ccccc12
Standard InChI: InChI=1S/C13H10N4/c14-9-5-7-6-15-17-12(7)11-8-3-1-2-4-10(8)16-13(9)11/h1-6,16H,14H2,(H,15,17)
Standard InChI Key: REIAHGBNCYVNDI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 222.25 | Molecular Weight (Monoisotopic): 222.0905 | AlogP: 2.78 | #Rotatable Bonds: 0 |
Polar Surface Area: 70.49 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.41 | CX Basic pKa: 4.08 | CX LogP: 1.59 | CX LogD: 1.58 |
Aromatic Rings: 4 | Heavy Atoms: 17 | QED Weighted: 0.40 | Np Likeness Score: -0.63 |
1. Suchaud V, Gavara L, Saugues E, Nauton L, Théry V, Anizon F, Moreau P.. (2013) Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors., 21 (14): [PMID:23735828] [10.1016/j.bmc.2013.05.011] |
Source(1):